Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,079 | -5,388 | -2,843 | -2,488 | -9,340 |
| Depreciation Amortization | 172 | 120 | 61 | 266 | 205 |
| Accounts receivable | -3 | -2 | -2 | 3 | 7 |
| Accounts payable and accrued liabilities | -973 | -1,064 | -971 | 1,017 | 303 |
| Other Working Capital | -1,230 | -1,418 | -1,344 | 1,037 | 186 |
| Other Operating Activity | 1,524 | 1,434 | 1,159 | -9,296 | 1,213 |
| Operating Cash Flow | $-8,589 | $-6,318 | $-3,940 | $-9,461 | $-7,426 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -2,463 |
| PPE Investments | N/A | N/A | N/A | 8,987 | -13 |
| Purchase Of Investment | N/A | N/A | N/A | -2,962 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 3,000 | 2,500 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $9,025 | $24 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,811 | 1,811 | 1,811 | 8,847 | 5,662 |
| Other Financing Activity | -246 | -128 | -128 | 0 | 0 |
| Financing Cash Flow | $1,565 | $1,683 | $1,683 | $8,847 | $5,662 |
| Beginning Cash Position | 11,455 | 11,455 | 11,455 | 3,044 | 3,044 |
| End Cash Position | 4,431 | 6,820 | 9,198 | 11,455 | 1,304 |
| Net Cash Flow | $-7,024 | $-4,635 | $-2,257 | $8,411 | $-1,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,589 | -6,318 | -3,940 | -9,461 | -7,426 |
| Capital Expenditure | N/A | N/A | N/A | -13 | -13 |
| Free Cash Flow | -8,589 | -6,318 | -3,940 | -9,474 | -7,439 |